GO:0061709 reticulophagy: ER Turnover Pathway

Reticulophagy, formally annotated as GO:0061709, is the selective autophagy process in which parts of the endoplasmic reticulum are loaded into autophagosomes, delivered to the vacuole, and degraded in response to changing cellular conditions. This process is also known as ER-phagy or autophagy of the ER and represents a critical quality-control mechanism that maintains ER homeostasis and protects cells from proteotoxic stress. Because the ER is the largest intracellular membrane network and the site of protein folding and lipid synthesis, its selective turnover must be tightly regulated to avoid both uncontrolled degradation and pathological accumulation of damaged ER. Research over the past decade has identified dedicated reticulophagy receptors that tether ER membranes to the autophagic machinery. RETREG1/FAM134B was the first mammalian reticulophagy receptor to be characterized, and subsequent studies revealed additional receptors including CALCOCO1 and FAM134C. These receptors contain LC3-interacting regions (LIRs) that allow them to recruit autophagosomal membranes to the ER, thereby initiating selective engulfment of ER subdomains. The process is intimately linked to ER stress signaling, with ATF4 acting as a key transcription factor that links ER stress to reticulophagy induction in cancer cells. Understanding reticulophagy is important because its dysregulation has been implicated in a wide range of human diseases, including cancer, diabetic nephropathy, and viral infections. For researchers, reticulophagy represents a tractable pathway for therapeutic intervention, and CRISPR-based models are now indispensable for establishing causal relationships between reticulophagy genes and disease phenotypes. This article provides a research-grade overview of GO:0061709, covering its definition, molecular mechanisms, key genes, disease relevance, and experimental methods.

Reticulophagy (GO:0061709) is defined as the selective autophagy process in which parts of the endoplasmic reticulum are loaded into autophagosomes, delivered to the vacuole, and degraded in response to changing cellular conditions. In other words, it is the targeted recycling of ER membranes and proteins through the autophagy-lysosomal pathway, distinct from bulk autophagy because it selectively captures ER subdomains via dedicated receptors.

Reticulophagy is important because it serves as a primary quality-control mechanism for the endoplasmic reticulum, the organelle responsible for protein folding, lipid synthesis, and calcium storage. Without efficient reticulophagy, damaged or excess ER accumulates, leading to ER stress, activation of the unfolded protein response, and potentially cell death. This process is also a key determinant of cell fate decisions under stress, influencing whether cells adapt, survive, or undergo apoptosis. In disease contexts, reticulophagy can be protective or detrimental depending on the tissue and insult: it attenuates tubular injury in diabetic nephropathy, restrains BMP receptor signaling, and modulates cancer progression. Furthermore, viruses have evolved strategies to manipulate reticulophagy for their own replication, making it a host-pathogen interface of therapeutic interest.

The following genes and proteins are central to reticulophagy (GO:0061709), as supported by the verified literature.

Reticulophagy is regulated at multiple levels. Transcriptionally, ER stress activates the unfolded protein response, and ATF4 induces reticulophagy genes to promote adaptation in glioblastoma cells. Nutrient-sensing pathways, including mTOR and AMPK, control the core autophagy machinery that is required for reticulophagy. Receptor availability and competition also regulate the process; for example, CKAP4 competes with RETREG1/FAM134B for binding, thereby modulating reticulophagy in hepatocellular carcinoma. Additionally, the V-ATPase-ATG16L1-LC3C axis provides a distinct regulatory route for reticulophagy initiation. Post-translational modifications of receptors, though not fully covered by the verified citations, are likely to contribute to fine-tuning, but this article does not speculate beyond published data.

Reticulophagy plays context-dependent roles in cancer. In glioblastoma cells, ATF4 links ER stress to reticulophagy, supporting tumor cell adaptation and survival under stress. In hepatocellular carcinoma, CKAP4 competes with RETREG1/FAM134B for binding, thereby regulating reticulophagy and promoting cancer progression. These findings suggest that modulating reticulophagy could be a therapeutic strategy in cancers with high ER stress.

GSTK1 and RETREG1/FAM134B-mediated reticulophagy attenuates tubular injury in diabetic nephropathy through modulation of ER stress and apoptosis. This protective role highlights reticulophagy as a potential target for preserving kidney function in diabetes.

Reticulophagy is a component of host-pathogen interactions during viral infection. Viruses can manipulate reticulophagy to remodel ER membranes for replication or to evade immune detection, making this pathway relevant for antiviral drug development.

Autophagy, including reticulophagy, is a regulator of cell death decisions. Depending on the context, reticulophagy can promote survival by removing damaged ER or contribute to cell death when overwhelmed, and this balance is critical in diseases characterized by ER stress.

Live-cell imaging using fluorescently tagged ER markers and autophagosome markers (e.g., LC3) allows real-time monitoring of ER engulfment and delivery to lysosomes. Tagged knock-in of reticulophagy receptors enables tracking of receptor dynamics.

Transmission electron microscopy provides ultrastructural evidence of ER fragments within autophagosomes and autolysosomes, confirming reticulophagy at high resolution.

RNA sequencing can identify ATF4-dependent transcriptional programs induced by ER stress, while proteomics can quantify changes in ER protein abundance upon reticulophagy modulation.

Genome-wide CRISPR knockout screens can identify genes required for reticulophagy under stress conditions, and focused libraries can dissect receptor-specific pathways.

Researchers studying reticulophagy-related genes often need to determine whether a candidate gene is causally involved in ER turnover, stress adaptation, or disease progression. Establishing causality requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR services tailored to reticulophagy research, enabling reproducible and publication-ready experiments.

Reticulophagy (GO:0061709) is a selective autophagy pathway essential for endoplasmic reticulum quality control and cellular adaptation to stress. Its molecular machinery, centered on receptors such as RETREG1/FAM134B, CALCOCO1, and FAM134C, is tightly regulated by ER stress and nutrient signals. Dysregulation of reticulophagy contributes to cancer, diabetic nephropathy, and viral pathogenesis, making it a compelling therapeutic target. Advances in CRISPR-based models and multi-omics methods are accelerating the dissection of reticulophagy mechanisms and their disease relevance. Researchers can leverage EDITGENE's knockout, point-mutation, knock-in, overexpression, and screening services to generate robust experimental evidence and translate findings into clinical applications.